handling is poorly understood.
The recent identification of a number of novel proteins that mediate Mg 2ϩ transport has enhanced our understanding of how Mg 2ϩ is translocated across mammalian membranes. Some of these transporters have some similarity to those found in prokaryocytes and yeast cells. Human Mrs2, a mitochondrial Mg 2ϩ channel, shares many of the properties of the bacterial CorA and yeast Alr1 proteins. The SLC41 family of mammalian Mg 2ϩ transporters has a similarity with some regions of the bacterial MgtE transporters. The mammalian ancient conserved domain protein (ACDP) Mg 2ϩ transporters are found in prokaryotes, suggesting an ancient origin. However, other newly identified mammalian transporters, including TRPM6/7, MagT, NIPA, MMgT, and HIP14 families, are not represented in prokaryotic genomes, suggesting more recent development. MagT, NIPA, MMgT, and HIP14 transporters were identified by differential gene expression using microarray analysis. These proteins, which are found in many different tissues and subcellular organelles, demonstrate a diversity of structural properties and biophysical functions. The mammalian Mg 2ϩ transporters have no obvious amino acid similarities, indicating that there are many ways to transport Mg 2ϩ across membranes. Most of these proteins transport a number of divalent cations across membranes. Only MagT1 and NIPA2 are selective for Mg 2ϩ . Many of the identified mammalian Mg 2ϩ transporters are associated with a number of congenital disorders encompassing a wide range of tissues, including intestine, kidney, brain, nervous system, and skin. It is anticipated that future research will identify other novel Mg 2ϩ transporters and reveal other diseases. differential regulation; heterologous expression MAGNESIUM IS THE SECOND MOST abundant cation within the cell and plays an important role in many intracellular biochemical functions. Mg 2ϩ is required for the catalytic activity of numerous metalloenzymes and can also serve a purely structural role by stabilizing the conformation of certain Mg 2ϩ -and Ca 2ϩ -dependent domains, such as Ca 2ϩ -binding proteins and transcriptional regulatory proteins. Deficiency of this essential metal has been implicated in many diseases, ranging from hypertension, migraines, and asthma to osteoporosis and other bone disorders (119, 151, 172) . Intracellular free Mg 2ϩ concentration is on the order of 0.5 mM, which is 1-2% of the total cellular Mg 2ϩ (21, 109) . Accordingly, intracellular Mg 2ϩ is maintained below the concentration predicted from the transmembrane electrochemical potential. This control is achieved through a balance of Mg 2ϩ uptake, intracellular Mg 2ϩ storage, and Mg 2ϩ efflux. It is clear that Mg 2ϩ is transported into and out of a variety of intracellular organelle compartments, and there are likely dedicated Mg 2ϩ transporters for each step. The transporters comprising these pathways have only begun to be identified. Unlike our knowledge of other major cations, cellular Mg 2ϩ handling is poorly understood.
The purpose of this review is to describe some of the recent insights into the identification and function of mammalian Mg 2ϩ transporters. There is a large body of physiological evidence for mammalian Mg 2ϩ transporters, which have only begun to be identified on the molecular level (11, 51, 109, 117, 135, 148, 170) . In particular, I will detail, at some length, the novel Mg 2ϩ transporters that have been identified over the last several years. These will be examined from the perspective of the established and more characterized mammalian Mg 2ϩ channels, mitochondrial Mrs2 and TRPM7/6. I will briefly review plant, bacterial, and yeast transporters as they relate to our newly identified mammalian Mg 2ϩ transporters, because some of these proteins share characteristics with the more ancient forms of transporters. The identification and characterization of plant, prokaryote, and yeast Mg 2ϩ transporters have been extensively reviewed elsewhere (35, 70, 73, 138 transport (30, 36, 87, 93, 98, 105, 168) . CorA is the primary Mg 2ϩ uptake transporter in most prokaryotes (140) . It is constitutively expressed in bacteria and does not respond to external Mg 2ϩ levels (70) . CorA functions to transport Mg 2ϩ into cells against a concentration gradient via the transmembrane electrical potential (70) . Under some circumstances, CorA can also mediate Mg 2ϩ efflux (142) . The crystal structure of CorA has recently been elucidated (30, 87, 105) , and the biophysical aspects of Mg 2ϩ transport have been discussed (90) . The CorA protein comprises two transmembrane domains (TMs), with both termini in the cytosol (30) . The transporter functions as a pentamer in the shape of an externally directed funnel (30, 87, 105, 168) . The tip of the funnel is formed by the two transmembrane helices from each monomer and the large opening of the cone by the NH 2 -terminal regions. Putative metal-binding sites found at each NH 2 -terminal domain may play a role in channel gating or transporter function (30, 102) . All CorA family members have a highly conserved signature "F/Y-GMN-F" motif located near the external surface of the first TM, which forms part of the pore that is essential for Mg 2ϩ transport (75) . The GMN motif may provide a polar region for interacting with cations. Mg 2ϩ is an unusual cation: it has the smallest ionic radius and the largest hydrated size among the common biological cations (70) . The GMN region located in the pore of the funnel might discriminate between the hydrated and ionic radii to form a selective filter for substrates (73) . Mg 2ϩ may remain in hydrated form, or it may be partially dehydrated through a portion of its transit across the membrane (87, 105) . Further crystal structures of CorA are needed to shed light on mechanisms and conformational changes involved in Mg 2ϩ transport. A complete understanding of the crystal structure of the CorA transporter should shed light on the biophysical conformational changes of CorA with metal binding and movement of Mg 2ϩ , Co 2ϩ , and Ni 2ϩ through the transport pore (30, 87, 105, 168) . [In this and the following discussions, the divalent cation specificity will be mentioned, but because the selectivity analyses were performed under different conditions with different concentrations, the substrate profiles may not be physiologically relevant, inasmuch as external Mg 2ϩ concentrations are much greater than concentrations observed for the heavy metals. However, the substrate profile is informative in the comparison of different transporter characteristics.] Biophysical characterization of transport through CoA may also shed some light on how other Mg 2ϩ transporters function. Mrs2 Mg 2ϩ transporters. A member of the CorA family of Mg 2ϩ transporters is Mrs2, named for "mitochondrial RNA splicing2," because it was believed to be a suppressor of splicing defects in mitochondria of plants, yeast, and animals (7, 47, 75, 179 ). Mrs2 appears to have the same substrate selectivity as CorA and Alr1, in that it transports Mg 2ϩ , Co 2ϩ , and several other divalent cations (75) . Mrs2 has two predicted TMs and the GMN motif at the same relative position as in CorA (75) . Cross-linking studies have suggested that the Mrs2 transporter also functions as a pentamer in the mitochondrial membrane (75) . There is a family of transporters, termed AtMrs2, in the plant Arabidopsis thaliana with similar properties to Mrs2 (73, 132, 137) . Unlike Mrs2, AtMrs2 appears to be localized to the surface membrane, but like Mrs2, it has the GMN signature sequence and transports a number of divalent cations (81) . Only single genes of the Mrs2 type have been identified in invertebrates, whereas numerous AtMrs2 genes have been found in plants (35, 73 (35) . Alr1 protein comprises two TMs and possesses the conserved GMN motif, which has been shown to be essential for yeast Mg 2ϩ transport (78) . As with CorA and Mrs2, Alr1 functions as an oligomer (162) . The Alr1 transcript is increased in low-Mg 2ϩ environments, and the Alr1 protein is diminished with high external Mg 2ϩ , indicating that Alr1 expression is regulated in yeast (46) .
AtMGT1 Mg 2ϩ transporters. The Mg 2ϩ transporter family AtMGT was identified from A. thaliana, and it has homology to Mrs2 (81) . AtMGT has a similarity to another newly found transporter in yeast termed AtMrs2 (35) . Both transporters are inhibited by Al 3ϩ , so that overexpression of AtMGT improves (19) . It should be noted that this regulation has no similarity with M-box RNAs of the MgtE (23) . The only discernable similarity between the two metalloregulatory RNAs is that they utilize transcription attenuation-like genetic control (23) .
MAMMALIAN Mg 2؉ TRANSPORTERS
Mrs2 Mg 2ϩ transporter. The first mammalian Mg 2ϩ transporter to be identified at the molecular level was Mrs2 (mitochondrial RNA splicing2) of the inner mitochondrial membrane (7, 176) . Apparently, the deficiency in splicing with mutant Mrs2 was due to inadequate levels of Mg 2ϩ for ribozyme structure and function (47). Mitochondria are important in cellular Mg 2ϩ homeostasis, and, in turn, Mg 2ϩ is fundamental in mitochondrial respiratory functions (125) . Transport studies showed that mitochondrial Mg 2ϩ uptake is an electrogenic process driven by the inside-negative transmembrane voltage. Mitochondria contain large amounts of Mg 2ϩ , but only a small fraction is in the free ionized form (125) . Ionized Mg 2ϩ levels, as determined with Mg 2ϩ -sensitive fluorescent dyes, are on the order of 0.4 -0.8 mM (75) . The mammalian Mrs2 is a single nuclear gene that is distantly related to plasma membrane bacterial CorA and yeast Alr genes (180) . As with this family of proteins, the mammalian Mrs2 is characterized by the presence of the GMN motif near the COOH terminus (180) . As determined with patch-clamp experiments, Mrs2 mediates high-capacity Mg 2ϩ and Ni 2ϩ influx in isolated yeast mitochondria (125) . Overexpression of yeast Mrs2 increases Mg 2ϩ influx, whereas deletion of the gene nearly abolishes uptake, suggesting that it is the major transport system in yeast mitochondria and, presumably, in mammalian mitochondria (75) . There is evidence of other mitochondrial Mg 2ϩ transporters, but these contribute little relative to Mrs2 (75) . These data suggest that Mrs2 protein may mediate Mg 2ϩ transport in mammalian mitochondria. Schweyen and colleagues (7, 47, 180) studied Mrs2 amino acid structure to determine the relationship of group II intron splicing with changes in Mrs2 transport, inasmuch as both functions are associated. Because Mrs2 shares some amino acid sequences with bacterial CorA, the availability of the crystal structure of CorA may be informative in describing Mg 2ϩ movement through the mammalian Mrs2 protein (87, 105 (107, 127, 156) . TRPM proteins possess six predicted TMs. Hydrophobic regions between TM5 and TM6 are thought to contribute to the cation pore when four channel subunits coalesce to form the functional transporter (16) . Unlike other members of the TRPM channel superfamily, the homologs TRPM6 and TRPM7 possess a COOH terminus, Thr/Ser kinase, that belongs to an atypical family of eukaryotic ␣-kinases (107, 127) . According, these proteins are termed "chanzymes." TRPM6 and TRPM7 have alternatively spliced variants, termed M6 kinases, containing only the NH 2 terminus and the kinase domain (17, 120, 121) . The physiological role of these variants remains unclear (16 , a differential response of TRPM7 to the inositol trisphosphate inhibitor 2-aminoethoxydiphenyl borate, and a larger unitary conductance of TRPM6 than TRPM7 (55, 83, 150) .
TRPM6 is found along the full length of the intestine, along the kidney nephron (predominantly in distal convoluted tubules), and in lung and testis tissues (17, 127, 160) . TRPM6 protein is localized to the apical membrane of gastrointestinal and renal distal convoluted tubule, thus forming the entry pathway into the epithelial cell (127) . Because of its location, TRPM6 is important for Mg 2ϩ absorption across intestinal and renal epithelial cells. Using a positional cloning approach, Schlingmann et al. (128) and Walder et al. (163) found that the syndrome "hypomagnesemia with secondary hypocalcemia (HSH)" is caused by mutations in the TRPM6 gene. HSH is an autosomal-recessive disorder characterized by low serum Mg 2ϩ levels due to diminished intestinal Mg 2ϩ absorption and decreased renal Mg 2ϩ reabsorption. TRPM6 mutations identified in HSH patients comprise premature stop mutations, exon deletions, frame shifts, and inserted splice sites that lead to aberrant TRPM6 proteins, endoplasmic retention, and loss of function (126) . Patients uniformly manifest in early infancy with generalized convulsions, muscle spasms, and tetany that are refractory to anticonvulsant treatment. Severe and prolonged hypomagnesemia results in hypoparathyroidism and diminished parathyroid hormone levels, which lead to hypocalcemia (112 (68) . A mutated variant of TRPM7 has been found in patients with Guamanian amyotrophic lateral sclerosis and parkinsonism dementia (61, 62) . The evidence is that heterologous expression of mutated TRPM7 produces functional channels that show an increased sensitivity to inhibition by intracellular Mg 2ϩ , resulting in diminished Mg 2ϩ uptake (62) . To our knowledge, Mg 2ϩ balance has not been evaluated in these patients, nor has the beneficial effect of Mg 2ϩ therapy been tested.
An interesting facet of TRPM6 and TRPM7 transport function is the ability to form heterooligomeric TRPM6 and TRPM7 channel complexes. By a variety of approaches, Schlingmann and colleagues (16, 127, 128) demonstrated that TRPM7 was necessary for TRPM6 trafficking to the plasma membrane. Other TRPM channel members (TRPM1-4) could not heteromerize with the channel kinases and were unable to direct TRPM6 to the membrane (16, 127) . Because TRPM7 is functional on its own, TRPM6 is not needed for TRPM7 trafficking, but homooligomerization may be needed for correct positioning of TRPM7 to the plasma membrane. In support of these observations, Schmitz et al. (131) showed that TRPM7-deficient cells cannot be complemented by heterologously expressed TRPM6. In addition, they reported that TRPM6 can modulate TRPM7 function by phosphorylation (131) . They conclude that TRPM6 and TRPM7 are not functionally redundant but both are crucial components of Mg 2ϩ homeostasis. In support of this notion, Li et al. (83) reported that single-channel conductance and biophysical properties of TRPM6-TRPM7 heteromeric complexes are different from those of homomeric channels. All these studies suggest that TRPM6 is not functional without TRPM7. However, another research group reported that TRPM6 is fully functional in heterologously expressed cell lines (150, 156) . Further studies are needed to clarify this controversy. Although it is arguable whether TRPM6 can function on its own, it is clear from the HSH patients that TRPM7 cannot substitute for TRPM6 in intestinal or renal Mg 2ϩ absorption (127) . Another interesting characteristic of TRPM6 and TRPM7 is the ␣-kinase activity linked to the channel function. The advantages of this close association of the two functions are far from clear. Although it is apparent that deletion of the ␣-kinase domain does not abrogate transport, it may modulate the dose-response curve to intracellular Mg 2ϩ and Mg 2ϩ -ATP, so that there is suppression of channel gating at physiological intracellular Mg 2ϩ concentrations (16, 24, 90, 96, 124, 131) . Scharenberg (124) hypothesized that because the TRPM7 ␣-kinase is adjacent to the conducting channel of TRPM7, entry of Mg 2ϩ or Ca 2ϩ may produce local changes in free divalent cation in sufficient concentrations to activate the associated kinase domain. In Scharenberg's view, activation of the asso-ciated ␣-kinase would then signal various functions via other phosphorylated substrates and/or feedback to modulate TRPM7 channel gating. Thus TRPM7 could function as an "Mg 2ϩ sensor." In contrast to these earlier studies, Matsushita et al. (90) reported that TRPM7 transport is completely abolished with deletion of the kinase domain. They suggest that the kinase domain may play a role in channel assembly or subcellular localization to the plasma membrane. As reviewed by Scharenberg, this difference may depend on the TRPM7 constructs used or the fact that the transfected cells express a background of wild-type TRPM7 proteins. More recently, Demeuse et al. (24) demonstrated that physiological Mg 2ϩ -ATP concentrations can inhibit TRPM7 channels and strongly enhance the channel-blocking efficacy of free intracellular Mg 2ϩ . The nucleotide-mediated inhibition was lost in kinasedeficient mutants of TRPM7, whereas the Mg 2ϩ -dependent regulation was retained, but with reduced efficacy. They concluded that the nucleotide-dependent regulation of TRPM7 is mediated by the nucleotide-binding site on the endogenous kinase domain and interacts synergistically with an Mg 2ϩ -binding site on the channel extrinsic to the kinase domain (24) . Finally, Schmitz et al. (130) showed that TRPM6 kinase phosphorylated TRPM7 but TRPM7 kinase did not phosphorylate TRPM6. They speculate that TRPM6 phosphorylation of TRPM7 might alter its sensitivity to intracellular Mg 2ϩ and modulate Mg 2ϩ transport. Other possible functions of the kinase domain include a role in phospholipase signaling. The kinase domain associates with the C2 domain of PLC (120, 123) . Runnels et al. (120) reported that phosphatidylinositol 4,5-bisphosphate is required for TRPM7 channel activity. Takezawa et al. (147) showed that TRPM7 abolished activation of PLC␤ via muscarinic and thrombin receptors coupled to G q proteins. They provided evidence that TRPM7 activity is modulated by its own endogenous kinase domain, responding to changes in intracellular levels of cAMP induced by G i -and G s -coupled receptors (147) . More recently, Dorovkov and Ryazanov (27) showed that the TRPM7 ␣-kinase phosphorylates and activates annexin 1. Although it is known that annexin 1 interacts with many proteins and membranes to play a pleiotropic role in cytoskeletal dynamics, cell proliferation, and ion channel trafficking, the functional significance of annexin 1 phosphorylation by TRPM7 is not clearly understood (178). Clark et al. (18) demonstrated that activation of TRPM7 by bradykinin leads to a Ca 2ϩ -and kinase-dependent interaction with the actinomycin cytoskeleton. Su et al. (146) reported that TRPM7 regulates local Ca 2ϩ concentrations within peripheral adhesion complexes to activate m-calpain and initiate the disassembly or turnover of peripheral adhesion complexes. They suggest that TRPM7-dependent regulation of m-calpain may be important in cell adhesion, motility, metastasis, apoptosis, and ischemic cell death. In support of this notion, Aarts and Tymianski (1) reported that, after neural injury, TRPM7 may accelerate the anoxia-induced production of reactive oxygen species through mediation of Ca 2ϩ influx, thereby exacerbating cell death.
Finally, Krapivinsky and colleagues (6, 76) reported that TRPM7 is located in membranes of acetylcholine-secreting synaptic vesicles of sympathetic neurons and PC12 cells, where it is critical for spontaneous and voltage-stimulated neurotransmitter release. They used an elegant approach to show that TRPM7 conductance across the vesicle membrane is required for vesicle fusion and acetylcholine secretion (76).
They speculate that TRPM7 opening would allow ion exchange between the vesicular and subplasma membrane cytoplasm, which is crucial to vesicular fusion (6) . It is evident from these reports that TRPM7, through its kinase activity, might provide a cationic sensor-signaling link to many diverse cellular functions.
A growing list of hormones and other factors have been reported to influence TRPM6 and TRPM7 protein expression and, in some cases, TRPM6-and TRPM7-mediated Mg 2ϩ transport. Angiotensin II (59), aldosterone (77) , bradykinin (9, 104, 177) , epidermal growth factor (149), thrombin, (147), estrogen (48), metabolic acidosis/alkalosis (54, 82, 100), thiazide diuretics (101), the immunosuppressants tacrolimus (99) and cyclosporin A (69), and mechano-or osmo-induced stretch (4, 53, 102) have been implicated in alteration of TRPM7 and/or TRPM6 in a variety of cells. These changes may be mediated by covalent means, such as PLC-coupled receptors (77), or through controls at the transcript or protein level (49, 101, 116, 156) . Interestingly, parathyroid hormone or 1,25-dihydroxyvitamin D had no effect on TRPM6 expression (48). Groenestege et al. (48) . Our preliminary data support the latter observation (unpublished observations; 112). All these observations clearly show that TRPM7 and TRPM6 channel activity is influenced by numerous hormones and factors at different regulatory levels.
TRPM6 and TRPM7 have also been implicated in a number of disorders, including retinoblastoma growth (54), renal cell proliferation (67), cholera (30) , diabetes mellitus (75, 143) , osteoporosis (2), neuronal ischemic injury (172), endothelial dysfunction (104) , and hypertension (53, 151). It is apparent that these channels are pleiotropic, affecting numerous organ systems in many different ways.
In summary, the TRPM7 and TRPM6 channel kinase proteins are involved in a wide range of functions in cellular divalent cation metabolism. TRPM7 appears to have a greater multifunctional role, inasmuch as it is ubiquitously expressed, mediates Mg 2ϩ and Ca 2ϩ entry, and is involved in a number of functions related to the maintenance of cation balance, membrane adhesion, and cell growth. TRPM6 is limited in distribution and, by all accounts, is principally involved with epithelial Mg 2ϩ transport in the intestine and kidney. Despite this diversification, they have retained some of the same channel and enzyme properties.
STRATEGY FOR IDENTIFYING NOVEL Mg 2؉ TRANSPORTERS
Mammalian Mg 2ϩ homeostasis is a balance of epithelial intestinal Mg 2ϩ absorption and renal Mg 2ϩ excretion. The kidney plays a major role in control of vertebrate Mg 2ϩ balance, in part, by active Mg 2ϩ transport within the distal tubule of the nephron (109) . Using the Madin-Darby canine kidney cell line obtained from canine distal tubules and immortalized mouse distal convoluted tubule cells (MDCT), we showed that Mg 2ϩ entry is through specific and regulated Mg 2ϩ pathways that are controlled by a variety of hormonal influences (109) . However, these hormones do not provide selective control, inasmuch as they also affect Ca 2ϩ and, in some cases, Na ϩ and K ϩ transport (109). Our findings indicate that selective and sensitive control of Mg 2ϩ transport is regulated by intrinsic cellular mechanisms in intact animals and isolated cells cultured in media (21, 111) . For example, in cells cultured in low-Mg 2ϩ medium, Mg 2ϩ uptake is upregulated. This adaptive increase in Mg 2ϩ entry was shown to be dependent, in part, on de novo transcription, since prior treatment of the epithelial cells with actinomycin D prevented the adaptation to low extracellular Mg 2ϩ (21) . The data suggest that epithelial cells can somehow sense the environmental Mg 2ϩ concentration and, through transcription/translation-and posttranslation-dependent processes, alter Mg 2ϩ transport to maintain Mg 2ϩ balance. Our evidence is that about half of the upregulation of Mg 2ϩ transport with Mg 2ϩ restriction is due to transcription/translation-mediated increase in protein synthesis and half is due to posttranslational modification and recycling of transport proteins onto the plasma membrane (21, 111) . These conclusions from studies using isolated epithelial cells are consistent with our views of Mg 2ϩ conservation in the intact kidney (109, 111, 136) .
On the basis of the knowledge that epithelial Mg 2ϩ transport is regulated, in part, by differential gene expression, we used oligonucleotide microarray analysis to identify novel genes that encode Mg 2ϩ transporters (42) . The mRNA was isolated from MDCT cells and used for the microarray analysis. Subconfluent MDCT cells were grown in normal culture medium containing 0. -depleted or Mg 2ϩ replete for short times; in our experiments, we used 4 h. We showed that epithelial cells, in vivo or in vitro, respond rapidly to Mg 2ϩ restriction (22, 136) . Longer exposure to Mg 2ϩ -deficient diets or culture medium leads to stasis of epithelial cell growth, loss of cell viability, and, eventually, cell death. Genes identified after prolonged restriction reflect pathological changes, rather than physiological regulations. These comments refer to rapidly growing renal epithelial cells; some cell types, particularly neural and lymphocytic established and nonestablished, are more resilient to Mg 2ϩ deficiency. These may be more conducive to long-term studies (148, 151, 172) .
In our studies, the transcripts were isolated and amplified, cRNA was biotin-labeled and fragmented, and the probes were hybridized to Affymetrix MG U74 Bv2 and MG U74 Cv2 arrays representing ϳ24,000 mouse transcripts. Detailed protocols for data analysis, documentation of sensitivity and reproducibility, and other aspects of the quantitative microarray analysis are provided elsewhere (42) . Of ϳ24,000 transcripts, only 128 DNA fragments were significantly increased and 62 were decreased with diminished Mg 2ϩ . Inasmuch as only two sets of chips were used for each condition, we were not able to publish the entire results (5-6 sets are normally required for publication purposes). All positive candidates selected for further study were confirmed to be upregulated using real-time RT-PCR analysis.
For our purposes, we selected putative candidates for functional screening based on secondary structures conforming to typical membrane transporters. We tentatively identified 11 candidate genes from a database screen of the 128 DNA fragments, the transcripts of which were upregulated with low Mg 2ϩ . The differently regulated transcripts were represented in the expressed sequence tag database, and the associated genes were predicted to encode known or hypothetical proteins. Eight of these candidates coded novel Mg 2ϩ transporter proteins ( Table 2 ). The respective transcripts were resident in many different tissues and possessed highly conserved mammalian orthologs, suggesting that they fulfill housekeeping functions. Of the other candidates selected, one was an unnamed predicted protein, the transcript of which was upregulated but did not demonstrate Mg 2ϩ transport when expressed in Xenopus laevis oocytes. The second candidate encoded sideroflexin 4, a known mitochondrial Fe 2ϩ transporter (34) . Mutant mitochondrial sideroflexin and aberrant Fe 2ϩ transport have been associated with some anemias (34 ; however, on inspection of the predicted secondary structure, it appeared to encode a soluble protein with no predicted TMs. Because it did not conform to a hypothetical membrane transporter, we did not investigate it further. Accordingly, it appears that Mg 2ϩ -responsive genes can encode proteins with yet to be described functions and proteins that might not be directly related to Mg 2ϩ metabolism. We have not investigated the other candidates that increased in our arrays or the candidates that decreased, so other novel genes encoding transport proteins are likely present in the mammalian genome. Moreover, we used the first generation of Affymetrix platforms in these early studies, and these chips contained many errors, redundancies, and reversed DNA sequences. Accordingly, it would be informative to repeat these experiments using the newer generation of chips.
We used the Xenopus oocyte expression system to determine function and characterize transport of the selected candidate genes. Oocytes have the advantage, in that they efficiently express cRNA with high fidelity. Indeed, as much as 10% of the plasma membrane can be heterologously expressed protein. Accordingly, the expressed Mg 2ϩ transport is robust and easily measured. Mg 2ϩ uptake is so large that we normally decreased the amount of cRNA injected to avoid high mortality due to cellular Mg 2ϩ overload. The second advantage of using Xenopus oocytes is that they are able to express proteins in the oocyte plasma membrane that are normally found in mammalian intracellular organelles. Thus intracellular Mg 2ϩ transporters can be expressed and characterized in the oocyte surface membrane.
We used two approaches to characterize Mg 2ϩ transport expressed in Xenopus oocytes. 1) Steady-state membrane currents were recorded with the two-microelectrode voltageclamp technique, and I-V plots were constructed (42) . 2) To identify the major cation contributing to the measured currents, we used epifluorescence microscopy with the Mg 2ϩ -responsive mag-fura 2 fluorescent dye to measure Mg 2ϩ flux into single oocytes (38, 40) . Oocytes were injected with 50 M mag-fura 2 acid 20 min before experimentation. The chamber (0.5 ml) was mounted on an inverted microscope with a ϫ10 objective lens, and an I-V plot was determined. Subsequently, the oocytes were clamped at Ϫ70 mV for fluorescence measurements using a dual-excitation-wavelength spectrofluorometer with excitation for mag-fura 2 at 340 and 385 nm and emission at 505 nm. Results are presented as the ratio of fluorescence at 340 nm to fluorescence at 385 nm, which reflects the intracellular Mg 2ϩ concentration. (Fig. 1, A and 1B) . Transport of Mg 2ϩ by MagT1 is rheogenic and voltage-dependent, characteristic of channelmediated transport. Fluorescence with the Mg 2ϩ -sensitive probe mag-fura 2 confirmed that the currents were due to flux of Mg 2ϩ (Fig. 1C) . It is highly selective, inasmuch as only Mg 2ϩ evokes currents or increases the ratio of fluorescence at 345 nm to fluorescence at 280 nm in expressing oocytes. There was a close correlation of the results with the two independent methods. Note the association of Mg 2ϩ flux measured with fluorescence and Mg 2ϩ -induced currents determined with voltage-clamp performed on the same oocyte expressing MagT1 (Fig. 1D) . These results are consistent with the fact that the driving force for an electrogenic transporter is dependent not only on the gradients of substrate but also on the membrane potential.
Real-time RT-PCR demonstrated that MagT1 mRNA is markedly increased in a wide range of tissues in mice maintained on low-Mg 2ϩ diets and in epithelial cells cultured for short periods in low-Mg 2ϩ medium, as predicted by our starting premise that led to the use of microarray analysis (42) . These studies suggest that MagT1 may provide a selective and regulated pathway, likely a channel, for Mg 2ϩ transport in epithelial cells.
Interestingly, MagT1 possesses a sequence cassette in the fourth TM of the mature protein that is similar to the signature and Ca 2ϩ were not transported. In silico analysis of the pre- dicted human protein sequences demonstrated two other members of the SLC41 family, SLC41A2 and SLC41A3, with ϳ70% similarity to SLC41A1 (41, 43) . SLC41A2 and SLC41A3 mediated saturable Mg 2ϩ transport, with affinities of 0.34 and 1.5 mM, respectively (41, 44;unpublished observations presented in Fig. 3B ). Similar to SLC41A1, the two solute transporters were permeable to many divalent cations (Fig. 2B ) (unpublished observations). Although the three members of the SLC41 family transport a wide range of divalent cations, we conclude that they are primarily Mg 2ϩ transporters, because they mediate Mg 2ϩ flux in the concentration range normally found in extracellular and intracellular fluid, as reflected by the K m values.
Clearly, cationic specificity was not the same for the SLC41 transporters as for MgtE (140) . For example, SLC41A1 does not transport Co 2ϩ to any degree, and Ni 2ϩ is not a selective inhibitor of Mg 2ϩ transport. This is not surprising, inasmuch as SLC41A1 shares only 40% similarity with 2 of 12 membrane segments of the bacterial transporter, with an overall similarity of ϳ15%. SLC41 transport proteins prefer Mg 2ϩ as a substrate; nevertheless, it is evident that they could perform a physiological function within cells to transport several other divalent cations.
We used quantitative real-time RT-PCR analysis to show that SLC41A1-3 transcripts are present in many tissues of normal mice (41, 42) . Furthermore, the mRNAs in these tissues are increased with low Mg 2ϩ . The subcellular location of SLC41A1-3 protein has not been determined by immunohistochemistry, but functional studies suggest that it is localized to the plasma membrane (122 (Fig. 2C) . The other three members of this family, ACDP1, ACDP3, and ACDP4, also have a wide substrate permeability ( The ACDP family of proteins is conserved in some form from bacteria to humans (167) . The human ACDP has some similarity to CorC of Salmonella typhimurium, which has been implicated in Mg 2ϩ and Co 2ϩ homeostasis in bacteria (64) . Mutations in corC are associated with Co 2ϩ resistance; however, there is no evidence that CorC is a metal transporter (64) . Although another bacterial protein, CorA, is clearly an Mg 2ϩ transporter, the function of CorC proteins and their role in Mg 2ϩ homeostasis are not apparent (64) . CorC is only 18% similar to CorA and does not possess any apparent TMs. Finally, a gapped alignment of the human ACDP2 and bacterial CorC sequences showed only 35% identical amino acid residues, and those extended throughout most of both proteins. Accordingly, it is difficult to judge the relationship of ACDP2 functions to functions of the bacterial CorC.
Recently, Yang and colleagues (176) . Although they proposed that ACDP is a family of transport proteins, there was no direct evidence for this conclusion in their study. The transcripts for ACDP1-4 are widely distributed and are upregulated with Mg 2ϩ deficiency, particularly in the renal distal convoluted tubule cells and kidney, heart, and brain tissue (43) . The initial report of Wang et al. (164) that ACDPs were localized in the nucleus of a wide variety of cells led others to suggest that it is a cyclophilin-like protein. However, they subsequently showed that mouse ACDP1 protein was localized to the plasma membrane (165) .
Human ACDP1 has been linked to an inheritable disease termed urofacial syndrome (UFS) or Ochoa syndrome (103, 164, 165) . UFS is a rare but ethnically widely distributed disorder inherited as an autosomal-recessive trait. Subjects present with congenital obstructive uropathy due to a neurogenic bladder and a paradoxical inversion of the facial expressions when they attempt to smile or cry (102) . Ochoa (103) postulated that the location of the laughing and crying centers in the upper pons of the midbrain close to the micturition center may explain the connection between the facial and urinary abnormalities. This would suggest that ACDP1 may be important in this area of the brain. The role of ACDP1 and Mg 2ϩ transport in this disorder is not known (163, 164) .
NIPA Mg 2ϩ transporters. The fourth family of Mg 2ϩ transporters to be identified with microarray analysis comprises the NIPA genes designated nonimprinted in Prader-Willi/Angelman syndrome (8, 38, 97) . Prader-Willi syndrome is a genetic disorder that presents as a complex developmental and multisystem disorder. The basis for Prader-Willi syndrome is not a single gene defect but, rather, is thought to be a contiguous gene syndrome. At least 12 imprinted genes that have been identified in the 15q11-q13 region are candidates for Prader-Willi syndrome (12) . Two closely related genes in this region are hNIPA1 (NM_144599) and hNIPA2 (NP_001008892). They are located in tandem on human chromosome 15q11-q13 (12, 32) . The corresponding mouse mNIPA1 and mNIPA2 genes are located in tandem on chromosome 7C. Using an in silico search, we identified mouse mNIPA3 (EDL37829), located on chromosome 5, and mNIPA4 (NP_766112), located on chromosome 11B1.1 (38) . The corresponding human genes were identified by Lefèvre et al. (80) and termed hNPAL1 (BAG53022) and hIchthyin (NM_001099287). hNPAL1 and hIchthyin are located on 4p12 and 5q33.3, respectively. Human ichthyin shares 85% amino acid similarity with mouse NIPA4. All four members of the NIPA gene family encode Mg 2ϩ transporters (38, 39) . Because NIPA1 and NIPA2 genes are in tandem on chromosome 15q, they are likely paralogs. Unlike orthologs that commonly retain the same function in the course of evolution, paralogs evolve new functions, albeit related to the original one. Phylogenetic analysis suggests that NIPA1 diverged early from NIPA genes (38) . As noted by Chai and colleagues (12), NIPA1 and NIPA2 polypeptides each display 98% identity between the respective human and mouse orthologs, and these have a 55% identity to the respective fugu NIPAs, but there is only 32-36% identity between NIPA1 and NIPA2 within each of the species. NIPA2, NIPA3, and NIPA4 also show greater common identity in their ancestral invertebrate polypeptides than they do to NIPA1. The phylogenetic distance between NIPA1 and NIPA2 paralogs is as great as that between the orthologs. This observation led Chai and colleagues to suggest that NIPA1 and NIPA2 have evolved related but different functions. Because they encoded polypeptides with eight or nine predicted TMs, these workers suggested that these polypeptides might function as membrane receptors or transporters.
It was of interest that the transcripts of all four NIPAs were differentially upregulated by low Mg 2ϩ in our microarray assays. To determine their function, we expressed the respective cRNAs in Xenopus oocytes and performed voltage-clamp and fluorescence studies to characterize ion-mediated transport. The electrophysiological data gave evidence for a rheogenic process with inward currents in cRNA-injected oocytes (39) . In support of this conclusion, we performed flux studies with fluorescence spectrometry using the Mg 2ϩ -sensitive dye mag-fura 2 (38) . Mouse NIPA1, NIPA2, NIPA3, and NIPA4 mediated saturable Mg 2ϩ uptake with K m of 0.31, 0.66, 0.90, and 0.36 mM, respectively. Inasmuch as the extracellular and intracellular Mg 2ϩ concentrations are on the order of 0.5 mM, the affinity of NIPA-mediated transport is consistent with a physiological role in cellular Mg 2ϩ transport. A variety of divalent cations were used to determine the selectivity of the expressed NIPA-mediated Mg 2ϩ transport (Fig. 2D ). NIPA2 was very selective for Mg 2ϩ , whereas NIPA1, NIPA3, and NIPA4 transported several other cations as well as Mg 2ϩ (39). Rainer et al. (113) and Chai et al. (12) reported that the NIPA1 and NIPA2 transcripts were on the order of 1.9 -2.2 kb. They further showed the presence of two NIPA1 transcripts, 1.9 -2.2 and 7.5 kb, in human and mouse (12, 113) . The two NIPA1 mRNAs are constitutively expressed in all tissues tested but are especially enriched in brain tissue (12, 113) . Our results from Western analysis are consistent with these earlier observations (38) . Using a specific polyclonal antibody that we generated in rabbits, we showed that the endogenous NIPA1 protein is present in many tissues but is particularly abundant in brain. Interestingly, the major form in brain cells appears to be about twice the molecular size predicted from the amino acid sequence, which suggests that it may be a dimer. Many membrane receptors, transporters, and integral membrane proteins require dimerization or higher oligomerization for their activity. The NIPA2 and human ichthyin transcripts are also widely distributed, but NIPA2 mRNA is more abundant in kidney tissue and human ichthyin mRNA is particularly rich in keratinocytes, with little or no expression of either transcript in brain (39, 80) .
Within the cell, the mNIPA1 and mNIPA2 proteins were principally localized in the early endosomal compartment and the peripheral surface. There is evidence that human ichthyin and its Drosophila ortholog spichthyin are also localized to early recycling endosomes and the plasma membrane (20, 169) . The peripheral localization of the NIPA proteins suggests that they might play a role, such as mediation of Mg 2ϩ transport, at the surface membrane. In support of this notion is the observation of increased intracellular trafficking of NIPA proteins in response to Mg 2ϩ (38, 39) . There was an apparent increase in trafficking from the surface and aggregation in the endosomes in cells cultured in high Mg 2ϩ , whereas there was a marked movement of NIPA1 and NIPA2 to the plasma membrane with low Mg 2ϩ . Consistent with the Western blot analysis, there was a noticeable increase in total protein in epithelial cells grown in low Mg 2ϩ , with an apparent clustering of NIPA proteins in early endosomes and plasma membrane. We conclude that high Mg 2ϩ leads to diminished surface expression of NIPA proteins and sequestration in endosomes, whereas low Mg 2ϩ results in an increase in early endosomal NIPA protein and enhanced targeting to the surface membrane. These changes in protein expression likely account, in part, for the associated changes in Mg 2ϩ transport observed in expressing oocytes.
Although initially associated with the Prader-Willi syndrome, NIPA1 has also been more directly implicated in another distinct disorder termed autosomal-dominant hereditary spastic paraplegia (HSP). HSP comprises Ͼ30 genetic disorders, the predominant feature of which is a spastic gait (32) . Mutations in at least six genes, including NIPA1 (SPG6), have been associated with autosomal-dominant HSP. This heterogenous group presents with progressive lower limb spasticity and weakness. In the absence of other clinical features, these disorders are referred to as pure or uncomplicated HSP (32). Fink (32) reported that uncomplicated HSP was linked to chromosome 15q, comprising NIPA1. Additional studies by this group identified a nucleotide substitution at position 134 of the NIPA1 cDNA (134C¡G, reported as 159CG) that resulted in an amino acid substitution at position 45 of the NIPA1 protein (T45R) in SPG6-linked HSP kindred (115) . The T45R mutation occurs at a conserved residue at the interface of the first TM and the first putative outside loop, which would be expected to extend the first TM by three amino acids. More recently, three different research groups identified a missense substitution, G106R, in a number of large unrelated families (14, 95, 115) . The G106R mutation is located in a highly conserved amino acid region within the central portion of the third TM. This mutation would likely alter significantly the structure or processing of the protein. Using this knowledge, we have shown that the missense mutations G100R and T45R lead to a loss of function, suggesting that G100 and T45 sites are important, if not essential, in NIPA1-mediated Mg 2ϩ transport. The mutant NIPA1 proteins were retained in the endoplasmic reticulum of mammalian cells, rather than normally trafficking to the plasma membrane (38) . It was of interest that both mutant NIPA1 proteins demonstrated diminished Mg 2ϩ transport, even though they were present within the surface membrane of expressing oocytes. Moreover, Gly 106 and T45 are conserved among ortholog NIPA1 channels, supporting the notion that the mutation is strongly pathogenetic. There are no similar mutations in the other members of the NIPA family, either the paralog NIPA2 or the related NIPA3 and NIPA4. The significance of these differences in the biophysical functioning of the NIPA transporters remains to be examined. It is also interesting that G106R leads to complete loss of function, whereas T45R mediates some Mg 2ϩ transport (38) . It would be interesting to examine whether there are differences in clinical symptoms between these two groups of HSP patients.
Although the 15q11-q13 defect underlies Prader-Willi syndrome, the NIPA1 gene within the region does not appear to be directly responsible for the complex phenotype (12) . NIPA1 and NIPA2 are not normally thought to be imprinted; thus any mutational phenotypic expression would have to be through a dominant-negative gain of function. However, our results indicate a loss of function with the reported NIPA1 mutations. Stefan et al. (144) generated a transgenic mouse model of Prader-Willi syndrome (designated TgPWS) that has a deletion of 13 known imprinted and 10 nonimprinted genes, including NIPA2. Microarray analysis of the brains to ascertain the primary transcriptional changes failed to demonstrate a change in NIPA1 and NIPA2 expression, leading these authors to conclude that these were unlikely to be involved in this disorder (144) . Accordingly, it is unlikely that NIPA1 and NIPA2 are imprinted, nor are they likely to be directly associated with Prader-Willi syndrome.
Mutations in the hIchthyin gene provide the basis of one form of autosomal-recessive congenital ichthyosis (ARCI). ARCI is a heterogenous group of disorders with abnormal differentiation and desquamation of the epidermis, leading to widespread scaling and erythema of the skin. Lefèvre et al. (80) identified six homozygous mutations, including one nonsense and five missense mutations, in a large number of consanguineous families presenting with ichthyosis. The function of ichthyin in skin differentiation is not known. On the basis of the observation that lipid dysfunctions are involved with the other ARCI disorders, Lefèvre et al. suggested that ichthyin might perform as a membrane receptor for trioxilins of the hepoxilin pathway. Therefore, it was of interest that our data clearly showed that mouse NIPA4 and, presumably, human ichthyin could mediate plasma membrane Mg 2ϩ transport (39). It is not known whether ichthyin performs other biochemical functions in addition to Mg 2ϩ transport. It is not clear how an NIPA1 loss of function can give rise to a network hyperexcitability that is able to cause pure or uncomplicated HSP. Using magnetic resonance imaging, Hedera et al. (60) recently showed that early and severe spinal cord atrophy occurs in SPG6 HSP patients due to axonal loss, suggesting degeneration of the descending spinal cord tracts innervating the lower extremities. Our findings show that NIPA1 forms an Mg 2ϩ transporter. How a defective Mg 2ϩ transporter would lead to the phenotype of HSP is unclear. It is also not evident how an ichthyin mutation and loss of function would lead to aberrant keratinocyte differentiation and desquamation in ARCI. It would be difficult to imagine how altered Mg 2ϩ metabolism would result in aberrant keratinocyte differentiation and desquamation. To our knowledge, disturbances in Mg 2ϩ metabolism in individuals with HSP or ARCI have not been reported, nor has the effect of Mg 2ϩ supplementation been assessed. Moreover, because HSP and ARCI are clinically and genetically heterogenous groups of disorders, it is likely that numerous other factors and genes can contribute to the generation of the phenotypes observed in the HSP and ARCI spectra (60) . The commonality of the two disorders appears to involve dedifferentiation and degeneration of the respective spinal cord and skin cell types. There is some evidence that these changes may depend on the integrity of the microtubule cytoskeleton. Using a Drosophila fly model, Wang et al. (169) reported that spichthyin loss of function results in dysregulation of bone morphogenic protein signaling and the maintenance of axonal microtubules. If the basis for these observations is not Mg 2ϩ transport, then it is interesting to speculate that NIPA1 and ichthyin might have other functions.
MMgT Mg 2ϩ transporters. The fifth family of Mg 2ϩ transporters that we have identified by differential gene expression using microarray analysis is MMgT, membrane Mg 2ϩ transporter, a gene family comprising two members, MMgT1 (GenBank accession no. EU069461) and MMgT2 (GenBank accession no. EU069462) (45 (Fig. 2E) .
MMgT mRNA is found in many tissues. Subcellular localization with immunohistochemistry demonstrated that MMgT1 and MMgT2 fusion proteins are principally found in the Golgi complex and post-Golgi vesicles (45) . Consistent with the observation that low Mg 2ϩ increases MMgT1 and MMgT2 transcripts, there was an apparent increase in respective protein in the Golgi and post-Golgi vesicles. Also evident was the observation that MMgT1 and MMgT2 partially sorted to different post-Golgi organelles. We conclude that the differential expression of MMgT1 and MMgT2 is involved in control of Mg 2ϩ metabolism within the Golgi complex and post-Golgi vesicles.
In summary, we showed that MMgT1 and MMgT2 proteins are novel membrane Mg 2ϩ transporters that reside in the Golgi and post-Golgi vesicles. A number of points are of interest. 1) MMgT1 and MMgT2 transcripts are present in a wide variety of tissues, suggesting a housekeeping role for the two transporters in cellular Mg 2ϩ metabolism.
2) The proteins comprise only two predicted TMs, implying that they form functional oligomers. It suggests that they may form homoand, perhaps, heterooligomeric units, inasmuch as it is generally thought that proteins with only two TMs are not sufficient to form a functional transporter. Many membrane receptors, transporters, and other integral membrane proteins require dimerization or higher oligomerization for their activity. Inasmuch as MMgT1 or MMgT2 forms functional transporters when expressed alone in oocytes, they must at least act as homomultimeric proteins, but they may form heterooligomers and, thereby, have different functional and morphological properties. The fact that MMgT1 and MMgT2 colocalize within the Golgi complex might suggest that they undergo heterooligomerization. The redundancy of two Mg 2ϩ transport proteins in the same subcellular compartment is also of interest, inasmuch as it may be important in maintaining cellular Mg 2ϩ balance, but it may also lend itself to mutationally induced dominant-negative inhibition of function. Finally, the presence of MMgT proteins in post-Golgi vesicles suggests that they might play additional roles downstream from the Golgi complex. They partially colocalize to the early endosomes, but a significant amount traffics to other post-Golgi vesicles. Interestingly, they appear to sort to separate organelle compartments, suggesting that they may ultimately subserve different functional roles in Mg 2ϩ metabolism. The identity of these organelle compartments and the function of MMgT1 and MMgT2 remain to be clarified.
HIP14 Mg 2ϩ transporters. Additionally, the microarray results indicated that HIP14 (huntingtin-interacting protein 14)-like (HIP14L) mRNA was markedly upregulated by low Mg 2ϩ . A polyglutamine [poly(Q)] expansion in the huntingtin protein is the basis of Huntington disorder (26) . One of the huntingtin-interacting proteins was identified by the yeast twohybrid system as HIP14 (139) . HIP14L, with 69% similarity to HIP14, was identified with an in silico database search (139) .
As with huntingtin protein, HIP14 and HIP14L are evolutionarily conserved, widely distributed among tissues, and appear to be located in the Golgi and post-Golgi cytoplasmic vesicles (139) . Recently, HIP14 and HIP14L have been shown to be palmitoyl acyltransferases by virtue of a DHHC cysteine-rich motif located between TM2 and TM3 (28) . Palmitoyl acyltransferases mediate palmitoylation and trafficking of multiple cellular proteins (28, 67, 175) . It was thus surprising that our microarray analysis indicated that the HIP14L transcript was responsive to Mg 2ϩ (40) . However, inasmuch as the secondary structures fit our parameters for a candidate Mg 2ϩ transporter, we further characterized their biological functions.
Our evidence indicates that HIP14 and HIP14L mediate Mg 2ϩ transport, and the data of Huang and Ducker and their respective colleagues (28, 65) indicate that these proteins mediate acyl palmitoylation of a number of proteins, including themselves, through a process of autopalmitoylation. The evidence that HIP14 and HIP14L are Mg 2ϩ transporters is persuasive (40 (65) . In confirmation, Varner et al. (157) used peptides that mimic distinct palmitoylation motifs and HPLC to measure in vivo palmitoylation. They showed that HIP14 is a palmitoyl acyltransferase with a preference for the farnesyl-dependent palmitoylation motif found in H-and N-RAS (28). More recently, Yanai et al. (175) reported that HIP14 palmitoylates huntingtin, which is essential for huntingtin trafficking and function. Moreover, HIP14 itself is palmitoylated by hetero-and homopalmitoylation (65) . Thus it is clear that the DHHC sequence of HIP14 has enzymatic functions, in addition to mediation of Mg 2ϩ transport. Accordingly, HIP14 and HIP14L are chanzymes, i.e., proteins that demonstrate fused channel and enzyme activities (107, 120, 127) .
Palmitoylation (or thioacylation) of cysteine residues has recently emerged as a reversible posttranslational modification involved in regulated trafficking and functional modulation of membrane proteins. Palmitoylation is a relatively common phenomenon within the cell and plays a prominent role in subcellular localization and regulation of acyltransferases and thioesterases and their cognate substrates that cycle on and off membranes (85, 129) . As reviewed by Linder and Dechenes (85) , palmitate exerts its effects primarily through interactions with lipid bilayers. In this context, HIP14 palmitoylates huntingtin and prevents it from forming aggregates, thus performing an essential function in protein trafficking. Additionally, palmitoylation activates many cation transporters, such as Na ϩ , K ϩ , and Ca 2ϩ channels (15, 50, 71, 92, 108) . It was of interest that HIP14 demonstrates protein acyltransferase activity, and metabolic labeling studies showed that HIP14 itself was palmitoylated through its innate DHHC domain (29) . HIP14 and HIP14L contain 11 cysteine residues in the predicted cytoplasmic loop region that are highly conserved and might function as palmitoylation sites. Accordingly, we speculated that palmitoylation might influence HIP14-mediated Mg 2ϩ transport. To determine whether the protein acyltransferase is necessary for transport function, we performed two types of experiments. 1) We used the specific inhibitor 2-bromopalmitate to block palmitoylation and determined its effects on HIP14-mediated Mg 2ϩ transport (65 (65) . Mg 2ϩ transport was decreased on the order of 50% in mutant HIP14⌬DHHC-expressing cells relative to wild-type HIP14-expressing oocytes, again according to voltage-clamp experiments and fluorescence studies. The HIP14⌬DHHC-tagged construct localized to the surface membrane of the oocyte. The residual Mg 2ϩ transport observed with DHHC deletion was similar to that observed with maximal 2-bromopalmitate inhibition. Furthermore, 2-bromopalmitate did not inhibit the residual Mg 2ϩ transport observed with HIP14⌬DHHC, indicating that both approaches, inhibition and deletion, had the same effect. Taken together, these data suggest that palmitoylation activates HIP14-mediated Mg 2ϩ transport. In support of this conclusion, coexpression of GODZ, an independent acyltransferase (31, 155) , with the mutated HIP14⌬DHHC stimulated Mg 2ϩ uptake to levels not unlike those observed for the wild-type HIP14 alone. GODZ was present on the surface of GODZ-expressing oocytes. GODZ alone did not stimulate Mg 2ϩ transport in oocytes, indicating that palmitoylation did not have a general effect but required the HIP14 protein. It further supports the idea that native oocytes do not possess endogenous protein acyltransferase, which is able to palmitoylate HIP14 protein. Additionally, 2-bromopalmitoylate inhibited the stimulation of transport by GODZ in HIP14⌬DHHC-expressing oocytes, again to transport rates similar to that of wild-type HIP14 plus 2-bromopalmitate. These studies strongly argue for a role of the HIP14 palmitoyl acyltransferase in modulating HIP14-mediated Mg 2ϩ transport function through a process of autoacylation. Finally, coexpression of wild-type HIP14 with GODZ in the oocytes did not stimulate Mg 2ϩ transport above rates observed for HIP14 alone. This suggests that heterologously expressed HIP14 is normally fully activated (autoacylated), so that regulation of transport function involves deacylation. This is consistent with the notion that acylation of cysteinyl-containing proteins is spontaneous and driven by local acyl-CoA concentrations (85) .
Huntington disease is a progressive neurodegenerative disorder that affects ϳ1 in 10,000 individuals, predominantly Europeans and North Americans. Typically, symptoms begin at 35-50 yr of age. It is characterized by a gradual loss of neurons, particularly the medium spiny neurons of the striatum. The disease is caused by an expansion of the CAG repeat in the huntingtin gene, which confers an expanded poly(Q) stretch in the huntingtin protein (26) . The function of the huntingtin protein is unclear. It interacts with many cytoskeletal and synaptic vesicle proteins that are essential for exocytosis and endocytosis (69, 158) .
The potential implications of HIP14-mediated cation transport are numerous. Relevant to the present findings is the observation that huntingtin has been implicated in cellular iron acquisition and utilization (3, 5, 61, 86, 91) . Patients with Huntington's disease often demonstrate abnormalities of iron homeostasis, including decreased serum ferritin, increased brain ferritin, increased transferritin receptor, and decreased iron-requiring enzymes (3, 5, 13, 86, 91) . It is appealing to speculate that the expanded poly(Q) tract alters huntingtin binding with its associated proteins, so that endocytic vesicle trafficking of HIP14 is abnormal, leading to aberrant release or accumulation of divalent cations into these organelles. This notion has gained some support from studies using various cell and animal models (35, 86, 91, 153, 173) . Given the pleiotropic nature of huntingtin functions, it is unlikely that altered cation transport is the sole cause of Huntington's disease, but a clearer picture of HIP14 physiology should increase our understanding of the disease progression.
Interestingly, we recently showed that GODZ mediates Ca 2ϩ uptake when expressed in oocytes. GODZ does not transport Mg 2ϩ , and HIP14 does not transport Ca 2ϩ (unpublished observations). However, both transporters are regulated by palmitoyl acyltransferase. It may be that the ability to mediate cation transport is a common feature of these types of palmitoyl acyltransferases.
Other mammalian Mg 2ϩ transporters. We recently identified two more novel genes encoding Mg 2ϩ transporters that are differentially regulated by Mg 2ϩ . Both are listed in the GenBank database as hypothetical proteins. The first we have termed MagC1 (Goytain and Quamme, unpublished observations). MagC1 DNA is highly conserved among many species. The transcript is 1.5 kb on Northern blots, possesses three predicted TMs, is found in many tissues, particularly heart, kidney, and brain, and transports a number of divalent cations in addition to Mg 2ϩ (Goytain and Quamme, unpublished observations (Fig. 4) . The simplest transporter families are Mrs2 and MMgTs, which comprise only two TMs, whereas the most complicated are the SLC41s, which have 10
TMs. There are also no evident uniform amino acid sequence similarities among the various Mg 2ϩ transporters. The only transporters identified that demonstrate selective Mg 2ϩ substrate specificity are MagT1 and NIPA2. There are no obvious amino acid sequence similarities between these two transporters to indicate essential Mg 2ϩ -dependent structures. There are also no apparent similar motifs or sequences within or between other identified transport families (TRPM, MagT, SLC41, ACDP, MMgT, and NIPA), nor is there uniformity in the number of TMs required for Mg 2ϩ transport. Accordingly, many different structural designs have evolved to mediate Mg 2ϩ transport. Mg 2ϩ is notable in its physical properties: it is the most densely changed cation in biology, and the unhydrated Mg 2ϩ has the smallest diameter (0.65 Å), whereas the fully hydrated cation (5.0 Å) has the largest diameter. Mg 2ϩ binds water more strongly than other biologically relevant cations. Accordingly, there are some challenges in explaining how Mg 2ϩ moves across the membrane. This has been clarified somewhat with the recent crystallography studies of CorA and MgtE and the single-channel patch-clamp electrophysiology analysis of Mrs2 (30, 57, 87, 99, 125) . It has long been debated whether Mg 2ϩ is dehydrated on transport into the channel (70) . On the one hand, the large currents observed by Schindl et al. (125) argue for hydrated or partially hydrated cationic movement. On the other hand, it is difficult to explain the cationic selectivity without a charged filter within the channel pore, as would be expected with the highly Mg 2ϩ -selective MagT1 and NIPA2 transporters. As reviewed by Schindl et al., the outer membrane pore forming the Mg 2ϩ entry side comprises the GMN motif and numerous negative electrostatic charges, which might provide ionic selectivity in those transporters possessing the GMN motif (125) . As discussed by Niegowski and Eshaghi (98) , some of the reported interpretative discrepancies of the three crystallographic studies may be due to deviation in members of the CorA family.
The (Fig. 2B) . Accordingly, other criteria must be important in determining ionic selectivity. Our initial premise was that we could use substrate selectivity and inhibition specificity to characterize the various Mg 2ϩ transport families. We thought that these properties would be useful in identifying new transporters. However, it became apparent that there was as much diversity in cation permeability and inhibitor potency within each family as between families. Examples of this diversity is the inhibitor specificity between MagT1 and NIPA2 (39, 42) or cationic selectivity and inhibitor specificity within families of the four members of the NIPA family (Fig. 2D) . Accordingly, cationic selectivity and inhibitor specificity were not informative in describing families of Mg 2ϩ transporters. It supports the notion that mammalian Mg 2ϩ transporters cannot be solely identified by a signature motif. It also suggests that there are many ways to transport Mg 2ϩ across membranes.
ANCIENT AND MODERN MAMMALIAN Mg 2؉ TRANSPORTERS
Some of the mammalian Mg 2ϩ transporters have amino acid sequence runs similar to those found in plants (Arabidopsis), bacteria, and yeast proteins. Human Mrs2 has ϳ23% amino acid similarity to Arabidopsis AtMrs2, bacterial CorA, and yeast Mrs2, and human SLC41 has ϳ15% similarity to MgtE. However, gapped alignment of these sequences shows only a few identical residues between the human and bacterial sequences extending throughout most of both proteins. The overall similarities are not close, and it is unlikely that one would identify mammalian Mg 2ϩ transporters by in silico screening of the human genome with prokaryotic sequences. Nevertheless, in some instances, as shown by Wabakken et al. (161) , regions of amino acid similarity can be found, if the shared amino acids are not randomly distributed within the protein but, rather, regionally located within putative integral portions, particularly if they form TMs. These common amino acid regions form important structures within the transporter pore. However, except for the GMN motif shared between the bacterial CorA and Arabidopsis, yeast, and human Mrs2, there appears to be no unique signature sequence between the ancient and the modern transporters. Moreover, the cationic selectivity of these transporters is diverse, within families as well as between family members, so it is not surprising that they do not share uniform sequence regions. TRPM (TRPM6 and TRPM7), MagTs (MagT1 and N33), NIPA (NIPA1-4), MMgTs (MMgT1 and MMgT2), and HIP14 (HIP14 and HIP14R) have no obvious similarities with any plant, bacteria, and yeast proteins; accordingly, they may have developed later in evolution.
PRIMARY DISEASES ASSOCIATED WITH MAMMALIAN Mg

2؉
TRANSPORTERS
A number of primary disorders have been associated with the newly identified Mg 2ϩ transporters, including HSH, Guamanian amyotrophic lateral sclerosis, parkinsonism dementia, UFS, HSP, ichthyosis (ARCI), and Huntington disease. Although the incidence of these disorders individually is relatively uncommon, together the currently known genes affect ϳ1 in 5,000 people. The genes are widespread among tissues, so it is not surprising that they encompass a variety of tissues, demonstrating a diversity of phenotypic presentations. Except for TRPM6, the role of these transporters in the pathology of these disorders is largely unknown. Moreover, some of these disorders are late onset, presenting in individuals in their 30s-50s. This would suggest a temporal regulation of the affected genes. It is expected that other diseases will be found that are associated with these and yet-to-be-identified Mg 2ϩ transporters. 
